Evidence map›Paper›PMID 37382409›Full record

ArticleInternational journal of stroke : official journal of the International Stroke Society2024

Analysis of brain edema in RHAPSODY.

Riana L Schleicher, Pongpat Vorasayan, Megan E McCabe, Matthew B Bevers, Thomas P Davis, John H Griffin, Archana Hinduja, Ashutosh P Jadhav, Jin-Moo Lee, Robert N Sawyer and 6 more

Open access · greenAbstract read
In one paragraph

Article in International journal of stroke : official journal of the International Stroke Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 2 countries.

Riana L SchleicherDivision of Neurocritical Care and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-3743-7922
Pongpat VorasayanDivision of Neurocritical Care and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Megan E McCabeDepartment of Biostatistics, University of Iowa, Iowa City, IA, USA.ORCID 0000-0002-4080-7584
Matthew B BeversDivisions of Stroke, Cerebrovascular and Critical Care Neurology, Brigham and Women's Hospital, Boston, MA, USA.
Thomas P DavisDepartment of Pharmacology, University of Arizona Health Sciences, Tucson, AZ, USA.
John H GriffinDepartment of Molecular Medicine, Scripps Research, La Jolla, CA, USA.
Archana HindujaDepartment of Neurology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
Ashutosh P JadhavBarrow Neurological Institute, Phoenix, AZ, USA.
Jin-Moo LeeDepartment of Neurology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Robert N SawyerDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
Berislav V ZlokovicDepartment of Physiology and Neuroscience, Keck School of Medicine of USC, Los Angeles, CA, USA.
Kevin N ShethDivision of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, Yale University, New Haven, CT, USA.
Janel K FedlerDepartment of Biostatistics, University of Iowa, Iowa City, IA, USA.
Patrick LydenDepartment of Physiology and Neuroscience, Keck School of Medicine of USC, Los Angeles, CA, USA.
W Taylor KimberlyDivision of Neurocritical Care and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
NN104 Investigators
Keck Hospital of USC · USMassachusetts General Hospital · USUniversity of Iowa · USBarrow Neurological Institute · USBrigham and Women's Hospital · USKing Chulalongkorn Memorial Hospital · THScripps Institution of Oceanography · USThe Ohio State University Wexner Medical Center · USUniversity at Buffalo, State University of New York · USUniversity of Arizona · USWashington University in St. Louis · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical TrialU01NS077179 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Merit E CUDKOWICZ, Aleksandar Videnovic · 2011 to 2026
$43.4M
Network of Excellence in Neuroscience Clinical Trials (NEXT)-DCCU01NS077352 · NINDS · UNIVERSITY OF IOWA · PI CHRISTOPHER S. COFFEY · 2011 to 2026
$28.1M
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic strokeU01NS088312 · NINDS · CEDARS-SINAI MEDICAL CENTER · PI LYDEN, PATRICK D · 2014 to 2017
$7.4M
Regulation of Protein C PathwaysR01HL142975 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI GRIFFIN, JOHN H, MOSNIER, LAURENT OLIVIER · 2018 to 2025
$7.3M
Portable, Low Field Brain Magnetic Resonance Imaging (MRI) for Acute StrokeR01EB031114 · NIBIB · YALE UNIVERSITY · PI William Taylor Kimberly, Matthew Scot Rosen · 2022 to 2026
$3.5M
Metabolomic predictors of stroke in REGARDSR01NS099209 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI KIMBERLY, WILLIAM TAYLOR · 2017 to 2021
$2.4M
Role of Soluble ST2 in Immune Cell Regulation and Secondary Neurologic Injury After Intracerebral HemorrhageK23NS112474 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI BEVERS, MATTHEW BRADFORD · 2020 to 2024
$1.1M
Brain endothelium and innate immune responses after strokeR21NS120002 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI KIMBERLY, WILLIAM TAYLOR · 2021 to 2021
$451k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL142975NIBIB NIH HHS R01 EB031114NINDS NIH HHS K23 NS112474NINDS NIH HHS R01 NS099209NINDS NIH HHS R21 NS120002NINDS NIH HHS U01 NS077179NINDS NIH HHS U01 NS077352NINDS NIH HHS U01 NS088312
6 · The paper itself

Abstract

backgroundCerebral edema is a secondary complication of acute ischemic stroke, but its time course and imaging markers are not fully understood. Recently, net water uptake (NWU) has been proposed as a novel marker of edema.

aimsStudying the RHAPSODY trial cohort, we sought to characterize the time course of edema and test the hypothesis that NWU provides distinct information when added to traditional markers of cerebral edema after stroke by examining its association with other markers.

methodsA total of 65 patients had measurable supratentorial ischemic lesions. Patients underwent head computed tomography (CT), brain magnetic resonance imaging (MRI) scans, or both at the baseline visit and after 2, 7, 30, and 90 days following enrollment. CT and MRI scans were used to measure four imaging markers of edema: midline shift (MLS), hemisphere volume ratio (HVR), cerebrospinal fluid (CSF) volume, and NWU using semi-quantitative threshold analysis. Trajectories of the markers were summarized, as available. Correlations of the markers of edema were computed and the markers compared by clinical outcome. Regression models were used to examine the effect of 3K3A-activated protein C (APC) treatment.

resultsTwo measures of mass effect, MLS and HVR, could be measured on all imaging modalities, and had values available across all time points. Accordingly, mass effect reached a maximum level by day 7, normalized by day 30, and then reversed by day 90 for both measures. In the first 2 days after stroke, the change in CSF volume was associated with MLS (ρ = -0.57,

conclusionsExisting cerebral edema imaging markers potentially describe two distinct processes, including lesional water concentration (i.e. NWU) and mass effect (MLS, HVR, and CSF volume). These two types of imaging markers may represent distinct aspects of cerebral edema, which could be useful for future trials targeting this process.

Indexed as

Brain EdemaBrain IschemiaIschemic StrokeStrokeEdemaHumansWaterWateredemaimaging markersIschemic stroke

Identifiers

PMID37382409
PMCPMC10789908
OpenAlexW4382501244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.